Allergan Reduces Head Count As Economy Batters Device Sales
This article was originally published in The Gray Sheet
Executive SummaryAllergan plans to cut 5% of its workforce to offset the impact of a decline in revenues that it blames on the global recession
You may also be interested in...
Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge related to its generic version of the NuvaRing contraceptive. However, the company’s shares jumped on a robust underlying performance that was praised by analysts.
Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.